Nutrafol Co-Founder Tsetis Invests Nearly $40 Million via Family Office, Pledges $7 Million to Charity
Giorgos Tsetis, co-founder and former chief executive of Nutrafol, has invested nearly $40 million through his family office Great Things over the past 18 months and pledged about $7 million in donations to nonprofits. The 41-year-old launched Great Things nearly a year ago after selling his remaining stake to Unilever in a deal valuing the company at $3.5 billion. The family office commits at least 20% of annual net realized profits to philanthropy, with three-to-five-year pledges supporting organizations including a Bronx after-school boxing academy and Every Cure.
Giorgos Tsetis, co-founder and former chief executive of Nutrafol, invests rapidly through his family office Great Things and commits at least 20% of annual net realized profits to philanthropy. Over the past 18 months, he has invested nearly $40 million and pledged approximately $7 million in donations and commitments to nonprofit organizations. Tsetis formally launched Great Things nearly a year ago after selling his remaining stake to Unilever in a transaction that valued the company at $3.5 billion. The 41-year-old said he hopes this model can serve as a reference for other wealthy families seeking to give back to society promptly.
Great Things' investment formula and its 20% minimum donation commitment are inspired by venture capital and private equity economics, and were structured with the assistance of Tsetis's financial adviser Gabriel Cooperman, a managing director at UBS Wealth Management. Cooperman noted that the model converts profit-sharing interests into charitable-sharing interests and considers the approach sustainable. The firm typically makes donation commitments spanning three to five years, supporting nonprofits including a Bronx after-school boxing academy and Every Cure, an organization dedicated to repurposing existing drugs to treat rare diseases.
Investment decisions at Great Things are made jointly by Tsetis and partner Roman Kalantari, with no external investors, enabling swift action. However, they have grown more cautious toward AI startups than previously, shifting focus to later-stage rounds to prioritize liquidity. Kalantari, who lived through the internet bubble era, believes the AI boom will eventually slow or undergo a correction, and stressed the importance of backing companies with durable value propositions built on their own technology rather than relying on OpenAI or Anthropic.
Great Things recently reinvested in Lila Sciences, a three-year-old company with proprietary AI models that operates automated robotics laboratories to accelerate scientific research. Its portfolio also includes Polymarket, a controversial prediction market startup. Tsetis said this is deliberate participation, aimed at achieving quick exits through secondary markets to generate returns while continuously monitoring the company's development.